About 11,713 results

ALLMedicine™ Anaphylaxis Center

Research & Reviews  3,269 results

Recent developments in the immunopathology of COVID-19.
Allergy Zhang HP, Sun YL et. al.

Nov 25th, 2022 - There has been an important change in the clinical characteristics and immune profile of Coronavirus disease 2019 (COVID-19) patients during the pandemic thanks to the extensive vaccination programs. Here, we highlight recent studies on COVID-19, ...

Perioperative Anaphylaxis.
Anesthesiology Tacquard C, Iba T et. al.

Nov 23rd, 2022 - Perioperative Anaphylaxis.|2022|Tacquard C,Iba T,Levy JH,|

Anaphylaxis in Pregnancy.
Immunology and Allergy Clinics of North America; Kuder MM, Baird R et. al.

Nov 22nd, 2022 - Anaphylaxis in pregnancy is a rare event, but has important implications for the pregnant patient and fetus. The epidemiology, pathophysiology, diagnosis, and treatment all carry important considerations unique to the pregnant patient. Common culp...

Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous per...
European Journal of Cancer (Oxford, England : 1990); Swain SM, Tan AR et. al.

Nov 22nd, 2022 - To characterise risk of anaphylaxis/hypersensitivity with intravenous pertuzumab plus trastuzumab (PH IV), the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) or concomitant chemotherapy to support poten...

Background rates of adverse events of special interest for COVID-19 vaccine safety moni...
Vaccine Moll K, Lufkin B et. al.

Nov 21st, 2022 - The U.S. Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative conducts active surveillance of adverse events of special interest (AESI) after COVID-19 vaccination. Historical incidence rates (IRs) of AESI are com...

see more →

Guidelines  22 results

Wilderness Medical Society Clinical Practice Guidelines on Anaphylaxis.
Wilderness & Environmental Medicine; Gaudio FG, Johnson DE et. al.

Feb 6th, 2022 - The Wilderness Medical Society convened a panel to review the literature and develop evidence-based clinical practice guidelines on the treatment of anaphylaxis, with an emphasis on a field-based perspective. The review also included literature re...

Anaphylaxis: Highlights from the practice parameter update.
Cleveland Clinic Journal of Medicine; Weller KN, Hsieh FH

Feb 3rd, 2022 - The practice parameter update on anaphylaxis from the Joint Task Force on Practice Parameters, with the collaboration of the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology, addresses...

EAACI guidelines: Anaphylaxis (2021 update).
Allergy Muraro A, Worm M et. al.

Aug 4th, 2021 - Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to recognize and manage. The European Academy of Allergy and Clinical Immunology Anaphylaxis multidisciplinary Task Force has updated the 2014 guideline. The gu...

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practic...
MMWR. Recommendations and Reports : Morbidity and Mortali... Choi MJ, Cossaboom CM et. al.

Jan 9th, 2021 - This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and...

see more →

Drugs  436 results see all →

Clinicaltrials.gov  201 results

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

Oct 14th, 2022 - To provide more information on safety profile of VAXZEVRIA in Japanese subjects, specific drug use result study in subjects with underling disease at higher risk of worsening COVID-19 is planned as an additional pharmacovigilance plan. The present...

Cause of Unexplained Anaphylaxis

Oct 13th, 2022 - Anaphylaxis is a severe life-threatening systemic hypersensitivity reaction caused by release of mediators from mast cells and basophils, characterized by cutaneous, respiratory, cardiovascular, or gastrointestinal signs and symptoms. The most com...

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Oct 7th, 2022 - This study is a non-randomized observation and comparison of immune response between bacteriologically confirmed TB patients under treatment cohort who received COVID-19 vaccine (n=54) vs healthy individuals (n=54). Each participant will receive s...

Lenvatinib Therapy in HCC Patients After LDLT

Oct 7th, 2022 - The research is an open, randomized, single-center study. Patients with high-risk recurrence of hepatocellular carcinoma who underwent liver transplantation are included according to the criteria of admission. Patients enrolled in the study were r...

The Quality of Life of Mothers of Children With Food Allergy

Sep 29th, 2022 - Food allergy (FA) derives from an abnormal immunological response to dietary antigens. On the basis of the immunological mechanism, FA are divided into the following forms: IgE-mediated, non-IgE-mediated and mixed. Prevalence, persistence and seve...

see more →

News  687 results

Epicutaneous Immunotherapy Promising in Young Peanut-Allergic Children

Nov 15th, 2022 - LOUISVILLE, Kentucky — A 12-month course of epicutaneous immunotherapy with a patch that contained 250 μg of peanut protein was associated with significant desensitization to peanut protein compared with placebo in peanut-allergic children aged 1 ...

Infant Anaphylaxis: Study Characterizes Symptoms, Treatment

Nov 14th, 2022 - LOUISVILLE, Kentucky — A majority of infants who presented to the emergency department (ED) with anaphylaxis appropriately received epinephrine, with symptoms typically resolving after a single treatment dose, research findings indicate. Given tha...

Epinephrine Autoinjectors Not Prescribed to Half of Adults With Severe Food Allergy

Nov 11th, 2022 - LOUISVILLE, Kentucky — Nearly half of adults with food allergies have not been prescribed an epinephrine autoinjector (EAI) by their physician, according to survey results presented here at the American College of Allergy, Asthma, and Immunology (...

Strategies to Treat Food Allergy With Oral Immunotherapy

Oct 28th, 2022 - Oral immunotherapy (OIT) for food allergy can help prevent anaphylaxis after accidental encounters with an allergen, but the treatment rarely cures the allergy, it has risks, and it requires long-term planning and shared decision-making by patient...

Here's How to Avoid a COVID-19 Vaccine Mix-Up

Sep 16th, 2022 - Recognizing the potential for vaccine administration errors with look-alike vials, CDC staff shared best practices for giving the right vaccine to the right person at the right dose, during a Clinician Outreach and Communication Activity (COCA) we...

see more →

Patient Education  70 results see all →